Idera Pharmaceuticals, Inc. (IDRA) To Host Conference Call And Webcast To Report Fourth Quarter And Full Year 2013 Financial Results On Thursday, March 13, 2014
3/6/2014 7:29:51 AM
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EDT on Thursday, March 13, 2014 to report its fourth quarter and full year 2013 financial results and provide a corporate update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by